FDA grants priority review for Nefecon, for patients with IgA nephropathy ...Middle East

STOCKHOLM, April 28, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the U.S. Food and Drug Administration (FDA) has accepted the submission and granted Priority Review for the New Drug Application (NDA) for...

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA grants priority review for Nefecon, for patients with IgA nephropathy )

Also on site :

Rough start dooms SB Foresters
Palestine Action activists charged over UK base break-in
Naveen Expresses Happiness as Odisha Ranked 5th Nationally in PGI-2.0 School Grading System

FDA grants priority review for Nefecon, for patients with IgA nephropathy ...Middle East

Tibetans in exile wonder: Will the next Dalai Lama be as charismatic as this one?

Saudi Arabia and Egypt discuss implementing Arab-Islamic Plan for Gaza reconstruction

Explosion kills former Lugansk mayor – media

Costco is now opening earlier for certain members

Man, 60, injured in shooting; RPD working to determine where it happened

How mobile pioneer Marty Cooper of Del Mar sparked the cellphone revolution

Zeds Dead Lives! The Duo Returns to Its Annual Red Rocks Gigs With a ‘Not Clean’ New Album — But Is It Dubstep?

Every Labour U-turn after PM reverses welfare cuts

‘Beyond the Gates’ Unnerves Fans With Week Of Reruns; Originals To Return July 7

MindsEye director reportedly says the studio will relaunch the game, as around 300 staff are at risk of being laid off

More than 600,000 cars recalled across Europe over engine issue

Texas beats out Miami, Penn State, others for in-state 4-star edge

US foreign policy is now a one-man reality show

Looking Back: Germany’s Four FIFA World Cup Wins

Amazon has a new performance review system: Stricter standards and what it means for employees